Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlie Schmidt

Showing results (61-70 of 113) with videos related to

Pageof 12
Sort By:
Journal of the National Cancer Institute|May 20, 2004
Metabolomics takes its place as latest up-and-coming "omic" scienceCharlie Schmidt
Journal of the National Cancer Institute|November 26, 2009
Costly cancer drugs trigger proposals to modify clinical trial designCharlie Schmidt
Journal of the National Cancer Institute|November 3, 2009
Why do tumors become resistant to antiangiogenesis drugs?Charlie Schmidt
Journal of the National Cancer Institute|October 2, 2015
Elective Neck Dissection in Early Oral Cancer: Debate ResolvedCharlie Schmidt
Journal of the National Cancer Institute|December 12, 2017
Human Microbiomes Influence Cancer TherapyCharlie Schmidt
Journal of the National Cancer Institute|November 13, 2008
Molecular breast imaging: potential new tool for detecting cancersCharlie Schmidt
Journal of the National Cancer Institute|February 8, 2007
SNPs not living up to promise; experts suggest new approach to disease IDCharlie Schmidt
Nature Biotechnology|March 9, 2007
Negotiating the RNAi patent thicketCharlie Schmidt
Journal of the National Cancer Institute|January 18, 2007
Adaptive design may hasten clinical trialsCharlie Schmidt
Journal of the National Cancer Institute|April 19, 2007
Public support for smoking bans diffusing to developing countriesCharlie Schmidt
Pageof 12

Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
Journal of the National Cancer Institute|May 20, 2004
Metabolomics takes its place as latest up-and-coming "omic" scienceCharlie Schmidt
Journal of the National Cancer Institute|November 26, 2009
Costly cancer drugs trigger proposals to modify clinical trial designCharlie Schmidt
Journal of the National Cancer Institute|November 3, 2009
Why do tumors become resistant to antiangiogenesis drugs?Charlie Schmidt
Journal of the National Cancer Institute|October 2, 2015
Elective Neck Dissection in Early Oral Cancer: Debate ResolvedCharlie Schmidt
Journal of the National Cancer Institute|December 12, 2017
Human Microbiomes Influence Cancer TherapyCharlie Schmidt
Journal of the National Cancer Institute|November 13, 2008
Molecular breast imaging: potential new tool for detecting cancersCharlie Schmidt
Journal of the National Cancer Institute|February 8, 2007
SNPs not living up to promise; experts suggest new approach to disease IDCharlie Schmidt
Nature Biotechnology|March 9, 2007
Negotiating the RNAi patent thicketCharlie Schmidt
Journal of the National Cancer Institute|January 18, 2007
Adaptive design may hasten clinical trialsCharlie Schmidt
Journal of the National Cancer Institute|April 19, 2007
Public support for smoking bans diffusing to developing countriesCharlie Schmidt
Pageof 12